6 Patents
- US124484292025T Cell Receptors Specific to B-cell Maturation Antigen for Treatment of Cancer
Dana-farber Cancer Institute, Inc.
0 cites - US121092662024Modulating Gabarap to Modulate Immunogenic Cell Death
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US120534682024Pharmaceutical Combinations Comprising a Histone Deacetylase Inhibitor and a CD38 Inhibitor and Methods of Use Thereof
Acetylon Pharmaceuticals, Inc.
0 cites - US120050732024Methods for Modulating Regulatory T Cells, Regulatory B Cells, and Immune Responses Using Modulators of the April-taci Interaction
Dana-farber Cancer Institute, Inc.
0 cites - US118021322023Small Molecules for Inducing Selective Protein Degradation and Uses Thereof
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US117024022023Small Molecules That Block Proteasome-associated Ubiquitin Receptor RPN13 Function and Uses Thereof
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites